APA (7th ed.) Citation

Peuker, C. A., Yaghobramzi, S., Grunert, C., Keilholz, L., Gjerga, E., Hennig, S., . . . Busse, A. (2022). Treatment with ribociclib shows favourable immunomodulatory effects in patients with hormone receptor-positive breast cancer: Findings from the RIBECCA trial. European journal of cancer, 162, . https://doi.org/10.1016/j.ejca.2021.11.025

Chicago Style (17th ed.) Citation

Peuker, Caroline Anna, et al. "Treatment with Ribociclib Shows Favourable Immunomodulatory Effects in Patients with Hormone Receptor-positive Breast Cancer: Findings from the RIBECCA Trial." European Journal of Cancer 162 (2022). https://doi.org/10.1016/j.ejca.2021.11.025.

MLA (9th ed.) Citation

Peuker, Caroline Anna, et al. "Treatment with Ribociclib Shows Favourable Immunomodulatory Effects in Patients with Hormone Receptor-positive Breast Cancer: Findings from the RIBECCA Trial." European Journal of Cancer, vol. 162, 2022, https://doi.org/10.1016/j.ejca.2021.11.025.